Columbia Partners L L C Investment Management Lowers stake in Zeltiq Aesthetics Inc (ZLTQ)

Zeltiq Aesthetics Inc (ZLTQ) : Columbia Partners L L C Investment Management reduced its stake in Zeltiq Aesthetics Inc by 19.19% during the most recent quarter end. The investment management company now holds a total of 462,951 shares of Zeltiq Aesthetics Inc which is valued at $17,518,066 after selling 109,944 shares in Zeltiq Aesthetics Inc , the firm said in a disclosure report filed with the SEC on Aug 10, 2016.Zeltiq Aesthetics Inc makes up approximately 1.24% of Columbia Partners L L C Investment Management’s portfolio.

Other Hedge Funds, Including , Tower Research Capital (trc) added ZLTQ to its portfolio by purchasing 2,813 company shares during the most recent quarter which is valued at $106,444. Zeltiq Aesthetics Inc makes up approx 0.01% of Tower Research Capital (trc)’s portfolio. Neuberger Berman Group sold out all of its stake in ZLTQ during the most recent quarter. The investment firm sold 45,345 shares of ZLTQ which is valued $1,591,156.California Public Employees Retirement System reduced its stake in ZLTQ by selling 8,300 shares or 10.13% in the most recent quarter. The Hedge Fund company now holds 73,600 shares of ZLTQ which is valued at $2,531,840.Great West Life Assurance Co Can boosted its stake in ZLTQ in the latest quarter, The investment management firm added 38,660 additional shares and now holds a total of 42,809 shares of Zeltiq Aesthetics Inc which is valued at $1,472,630.New York State Teachers Retirement System boosted its stake in ZLTQ in the latest quarter, The investment management firm added 200 additional shares and now holds a total of 47,852 shares of Zeltiq Aesthetics Inc which is valued at $1,558,061.

Zeltiq Aesthetics Inc closed down -0.48 points or -1.29% at $36.79 with 4,68,650 shares getting traded on Friday. Post opening the session at $37.26, the shares hit an intraday low of $36.72 and an intraday high of $37.63 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Zeltiq Aesthetics Inc reported $-0.12 EPS for the quarter, missing the analyst consensus estimate by $ -0.08 based on the information available during the earnings call on Aug 8, 2016. Analyst had a consensus of $-0.04. The company had revenue of $89.50 million for the quarter, compared to analysts expectations of $79.68 million. The company’s revenue was up 38.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.03 EPS.

Many Wall Street Analysts have commented on Zeltiq Aesthetics Inc. Company shares were Reiterated by Maxim Group on Aug 9, 2016 to “Buy”, Firm has raised the Price Target to $ 48 from a previous price target of $40 .

ZELTIQ Aesthetics Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. As of December 31 2014 it had an installed base of 3176 CoolSculpting systems installed across approximately 2688 practices across the world. As of December 31 2014 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Leave a Reply

Zeltiq Aesthetics Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zeltiq Aesthetics Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.